Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.44 (
P-glycoprotein
)
13,344
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
P-glycoprotein
(
PGP
), an active efflux pump of antitumor agents in multidrug-resistant tumor cells, exists in brain capillary endothelium and could be functionally involved in the blood-brain barrier. To study the regulatory mechanism of
PGP
expression in brain capillary endothelium, various mouse tissue matrices were tested for their abilities to enhance the expression of
PGP
in mouse brain capillary endothelial cells (MBEC), which express relatively small amounts of
PGP
. Of the four tissue matrices we examined,
PGP
expression in MBEC cultured on the brain matrix increased 2.0-fold. The
PGP
-inducing activity was similarly detected in bovine brain matrix, and the activity was enriched in the fraction of pl 9.0 by isoelectric focusing. The fraction, named
PIC
-fraction (
PGP
-inducing component), increased the
PGP
expression in MBEC 3.5-fold. By Northern blot analysis, a 3.3-fold enhancement of mdr gene expression was observed in MBEC cultured on the
PIC
-fraction. The
PGP
-inducing activity of the
PIC
-fraction was reduced by the treatment with trypsin but not with collagenase, suggesting that a proteinaceous factor distinct from type I collagen might be responsible for the
PGP
-inducing activity of
PIC
-fraction. Although the
PIC
-fraction increased the
PGP
expression in other mouse brain capillary endothelial cells, the
PIC
-fraction did not increase
PGP
expression in mouse aortic endothelial cells and KB carcinoma cell lines expressing various amounts of
PGP
. These observations suggest that
PGP
expression in brain capillary endothelium is specifically regulated by a tissue-specific factor in the brain matrix.
...
PMID:Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells. 784 16